-
News
Intravenous administration of high-dose vitamin C in addition to chemotherapy improves survival in patients with pancreatic cancer
-
News
It has been revealed how inhaling house dust mites triggers the development of allergic asthma
-
News
Liver cell aging can cause multiorgan failure
-
News
Study finds cannabis is genotoxic and carries cancer risk
-
News
Vitamin D supplementation may lower blood pressure in obese older adults
All news
Laryngeal cancer treatment
Laryngeal cancer is a malignant tumor in the epithelial tissue of the larynx or vocal cords. It accounts for 2.6% of all malignant neoplasms. It mainly occurs in men aged 40-65 years (80-95% of cases).
Types of laryngeal cancer:
- Squamous cell carcinoma — from dense non-secreting epithelium makes up 95% of cases;
- Adenocarcinoma is a malignant tumor from the glandular epithelium.
The five-year survival rate for laryngeal cancer is:
- At stages I-II from 75% to 90%;
- At stage III 63-67;
- At stage IV, 20%.
MedTour patients recommend clinics for the treatment of laryngeal cancer:
Doctors for the treatment of laryngeal cancer
Patient reviews
My mom had a mastectomy at the Samsung medical center. We were very worried, but everything went well. MedTour helped us get to the clinic and hired a transfer. The clinic is of a high class, my mother was pleased with the treatment, the conditions of the ward and the service.
I had prostate cancer and I decided to have a surgerv in Medipol clinic. I have heard about it from my friends to did the same surgery here. I was amazed about modern technology in this hospital! Doctors and nurses are super polite and educated. Everyone speaks english and is ready to help in every situation. My turkish surgeon was the best doctor, which I have ever met in my life. Results of the surgery are estounishing. I feel myself great and I am very thankful to MedTour for organizing my medical trip!
Published:
Updated:
Information on this webpage verified by the medical expert
Рудченко Олексадр Украіна. Велике спасибі за професіоналізм та чуйність до всього колективу відділення, особливо лікарю Марісу Межецкісу. Лікування відбувалося у січні 2023 року.